JPWO2022216514A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022216514A5 JPWO2022216514A5 JP2023561608A JP2023561608A JPWO2022216514A5 JP WO2022216514 A5 JPWO2022216514 A5 JP WO2022216514A5 JP 2023561608 A JP2023561608 A JP 2023561608A JP 2023561608 A JP2023561608 A JP 2023561608A JP WO2022216514 A5 JPWO2022216514 A5 JP WO2022216514A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- amino acid
- acid sequence
- seq
- ipsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171646P | 2021-04-07 | 2021-04-07 | |
| US63/171,646 | 2021-04-07 | ||
| US202163279837P | 2021-11-16 | 2021-11-16 | |
| US63/279,837 | 2021-11-16 | ||
| PCT/US2022/022793 WO2022216514A1 (en) | 2021-04-07 | 2022-03-31 | Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519515A JP2024519515A (ja) | 2024-05-15 |
| JPWO2022216514A5 true JPWO2022216514A5 (enrdf_load_stackoverflow) | 2025-04-08 |
Family
ID=81648414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561608A Pending JP2024519515A (ja) | 2021-04-07 | 2022-03-31 | 人工多能性幹細胞からガンマ－デルタｔ細胞を生成するための組成物および方法 |
Country Status (11)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023553419A (ja) | 2020-12-03 | 2023-12-21 | センチュリー セラピューティクス，インコーポレイテッド | 遺伝子操作細胞およびその使用 |
| US20240100093A1 (en) * | 2021-02-05 | 2024-03-28 | National University Corporation Kobe University | Gamma delta t cells derived from induced pluripotent stem cells, and production method therefor |
| WO2023164440A1 (en) | 2022-02-22 | 2023-08-31 | Juno Therapeutics, Inc. | Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses |
| WO2023240147A1 (en) | 2022-06-08 | 2023-12-14 | Century Therapeutics, Inc. | Genetically engineered cells expressing cd16 variants and nkg2d and uses thereof |
| WO2024103017A2 (en) | 2022-11-10 | 2024-05-16 | Century Therapeutics, Inc. | Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof |
| WO2024191989A1 (en) * | 2023-03-14 | 2024-09-19 | Shattuck Labs, Inc. | Treatment of b cell-mediated diseases by activating cd20-targeted gamma delta t cells |
| WO2024206992A2 (en) * | 2023-03-30 | 2024-10-03 | Yale University | Universal antibody receptors, guar-t cells and therapeutic use thereof |
| WO2024254013A1 (en) * | 2023-06-04 | 2024-12-12 | Cytovia Therapeutics, Llc. | Natural killer cells with novel il-15 knock-in and methods of use thereof |
| WO2025101938A2 (en) | 2023-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof |
| WO2025106626A1 (en) | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
| CN118845737A (zh) * | 2024-07-08 | 2024-10-29 | 海南大学 | 托瑞米芬在增强γδT细胞抗肿瘤功能中的应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344321B1 (en) | 1990-06-11 | 2002-02-05 | Gilead Sciences, Inc. | Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| PT656946E (pt) | 1992-08-21 | 2001-12-28 | Univ Bruxelles | Imunoglobulinas desprovidas de cadeias leves |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| WO2003016496A2 (en) | 2001-08-20 | 2003-02-27 | The Scripps Research Institute | Zinc finger binding domains for cnn |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8574179B2 (en) | 2004-09-17 | 2013-11-05 | Stp Swiss Therapeutic Products Ag | Enhanced biomechanical stimulation device |
| SG193652A1 (en) | 2007-03-23 | 2013-10-30 | Wisconsin Alumni Res Found | Somatic cell reprogramming |
| KR101871192B1 (ko) | 2008-06-04 | 2018-06-27 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | 비-바이러스 접근법을 사용한 ｉＰＳ 세포의 생산 방법 |
| CA2741090C (en) | 2008-10-24 | 2018-10-16 | Wisconsin Alumni Research Foundation | Pluripotent stem cells obtained by non-viral reprogramming |
| JP5816100B2 (ja) | 2009-02-27 | 2015-11-18 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | 多能性細胞の分化 |
| PT3964502T (pt) | 2009-03-19 | 2024-07-22 | Univ Johns Hopkins | Compostos que têm psma como alvo e as suas utilizações |
| KR102110608B1 (ko) | 2009-12-10 | 2020-05-14 | 리전츠 오브 더 유니버스티 오브 미네소타 | Ｔａｌ 이펙터-매개된 ｄｎａ 변형 |
| US9206394B2 (en) | 2010-02-03 | 2015-12-08 | The University Of Tokyo | Method for reconstructing immune function using pluripotent stem cells |
| EP2601289B1 (en) | 2010-08-04 | 2017-07-12 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| DE102012006356A1 (de) | 2012-03-28 | 2013-10-02 | Audi Ag | Kraftfahrzeug, umfassend mehrere aktive oder passive Sicherheitsvorrichtungen |
| US9932607B2 (en) | 2013-11-15 | 2018-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Site-specific integration of transgenes into human cells |
| US11124845B2 (en) | 2014-03-18 | 2021-09-21 | The Johns Hopkins University | PSMA-based molecular-genetic reporter system |
| CN114292817A (zh) | 2014-07-18 | 2022-04-08 | 国立大学法人京都大学 | 从多能性干细胞诱导细胞免疫治疗用t细胞的方法 |
| JP7061961B2 (ja) | 2015-10-20 | 2022-05-02 | フジフィルム セルラー ダイナミクス，インコーポレイテッド | 多能性幹細胞の免疫細胞への分化を誘導する方法 |
| ES2886631T3 (es) | 2016-04-15 | 2021-12-20 | Univ Kyoto | Método para inducir células T positivas para CD8 específicas de antígeno |
| CN116970630A (zh) | 2016-08-26 | 2023-10-31 | 贝勒医学院 | 用于细胞治疗的组成型活性细胞因子受体 |
| JP7215994B2 (ja) | 2016-09-06 | 2023-01-31 | ザ チルドレンズ メディカル センター コーポレーション | 人工多能性幹細胞由来の免疫細胞 |
| KR102397771B1 (ko) | 2016-09-23 | 2022-05-13 | 프레드 헛친슨 켄서 리서치 센터 | 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도 |
| US20200263139A1 (en) | 2016-10-05 | 2020-08-20 | FUJIFILM Cellular Dynamics, Inc. | Methods for directed differentiation of pluripotent stem cells to hla homozygous immune cells |
| EP3572502B1 (en) * | 2017-01-20 | 2023-01-11 | Kyoto University | Method for producing cd8alpha +beta + cytotoxic t cells |
| JP7224021B2 (ja) * | 2017-02-03 | 2023-02-17 | 国立大学法人神戸大学 | 人工多能性幹細胞の作製方法 |
| AU2018250336B2 (en) | 2017-04-07 | 2025-02-20 | Juno Therapeutics, Inc. | Engineered cells expressing prostate-specific membrane antigen (PSMA) or a modified form thereof and related methods |
| US12163155B2 (en) | 2017-04-18 | 2024-12-10 | FUJIFILM Cellular Dynamics, Inc. | Antigen-specific immune effector cells |
| CN118206655A (zh) | 2017-07-25 | 2024-06-18 | 得克萨斯大学体系董事会 | 增强的嵌合抗原受体及其用途 |
| EP3684816B1 (en) | 2017-09-22 | 2024-05-29 | Kite Pharma, Inc. | Chimeric polypeptides and uses thereof |
| US20200239544A1 (en) | 2017-10-03 | 2020-07-30 | Precision Biosciences, Inc. | Modified epidermal growth factor receptor peptides for use in genetically-modified cells |
| BR112020010597A2 (pt) * | 2017-12-08 | 2020-10-27 | Fate Therapeutics, Inc. | imunoterapias com o uso de células efetoras derivadas de ipsc intensificadas |
| SG11202100260QA (en) * | 2018-07-13 | 2021-02-25 | Univ Kyoto | METHOD FOR PRODUCING γδ T CELLS |
| EP3853351A1 (en) | 2018-09-19 | 2021-07-28 | FUJIFILM Cellular Dynamics, Inc. | Protein l for activation and expansion of chimeric antigen receptor-modified immune cells |
| TW202031894A (zh) * | 2018-11-01 | 2020-09-01 | 中國大陸商亘喜生物科技（上海）有限公司 | 用於t細胞工程之組合物及方法 |
| EP4267150A4 (en) * | 2020-12-28 | 2025-04-02 | The Regents of University of California | MODIFIED DELTA GAMMA T LYMPHOCYTES AND METHODS OF PREPARATION AND USE THEREOF |
-
2022
- 2022-03-31 MX MX2023011927A patent/MX2023011927A/es unknown
- 2022-03-31 CA CA3214045A patent/CA3214045A1/en active Pending
- 2022-03-31 IL IL307358A patent/IL307358A/en unknown
- 2022-03-31 AU AU2022252997A patent/AU2022252997A1/en active Pending
- 2022-03-31 WO PCT/US2022/022793 patent/WO2022216514A1/en active Application Filing
- 2022-03-31 BR BR112023018844A patent/BR112023018844A2/pt unknown
- 2022-03-31 KR KR1020237038118A patent/KR20230170703A/ko active Pending
- 2022-03-31 JP JP2023561608A patent/JP2024519515A/ja active Pending
- 2022-03-31 EP EP22723243.6A patent/EP4320227A1/en active Pending
- 2022-04-04 US US17/657,798 patent/US20220333073A1/en active Pending
- 2022-04-07 TW TW111113220A patent/TW202305113A/zh unknown
-
2024
- 2024-09-16 US US18/886,563 patent/US20250066728A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12233090B2 (en) | Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19 | |
| US11679132B2 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| US20250034217A1 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
| AU2018281316B2 (en) | Expression of novel cell tags | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| CN109562126A (zh) | 嵌合抗原受体(car)、组合物及其使用方法 | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| KR20180002604A (ko) | 혈액 악성종양을 표적으로 하는 키메라 항원 수용체(car), 조성물 및 이의 용도 | |
| CN106414748A (zh) | 嵌合抗原受体及制备方法 | |
| CN111201033A (zh) | 细胞 | |
| EP3823993A1 (en) | Chimeric receptors to steap1 and methods of use thereof | |
| JPWO2022216514A5 (enrdf_load_stackoverflow) | ||
| JPWO2022216624A5 (enrdf_load_stackoverflow) | ||
| CN114615992A (zh) | 表达t调节性细胞的抗cd83嵌合抗原受体 | |
| CN114929341A (zh) | 用于治疗髓系恶性肿瘤的嵌合抗原受体 | |
| KR20210111244A (ko) | 태반-유래 동종이계 car-t 세포 및 이의 용도 | |
| JPWO2022120334A5 (enrdf_load_stackoverflow) | ||
| US20240060089A1 (en) | Vector-free process for manufacture of engineered immune cells | |
| CN115397863A (zh) | Cd3融合蛋白及其用途 | |
| RU2822366C2 (ru) | Химерные антигенные рецепторы и связывающие агенты, нацеленные на dll3 | |
| CN117778328A (zh) | 一种通用型bcma car-t细胞的增殖方法 | |
| WO2024193714A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| CN116157415A (zh) | 靶向抗rh抗体的组合物和方法 |